These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6661605)

  • 21. Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinising hormone and follicle-stimulating hormone but not thyrotropin or substance P.
    Skrabanek P; Balfe A; Webb M; Maguire J; Powell D
    Psychoneuroendocrinology; 1981; 6(3):261-7. PubMed ID: 6170084
    [No Abstract]   [Full Text] [Related]  

  • 22. Parallel changes of the responses of thyrotropin, growth hormone and prolactin to thyrotropin-releasing hormone in endogenous depression.
    Kirkegaard C; Eskildsen PC; Bjørum N
    Psychoneuroendocrinology; 1981; 6(3):253-9. PubMed ID: 6794070
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of electroconvulsive therapy on the thyrotropin-releasing hormone test in patients with depression.
    Esel E; Kilic C; Kula M; Basturk M; Ozsoy S; Turan T; Keles S; Sofuoglu S
    J ECT; 2004 Dec; 20(4):248-53. PubMed ID: 15591859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone and somatomedin serum levels in patients with major depressive illness undergoing electroconvulsive therapy.
    Apéria B; Thorén M; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1986 Jun; 73(6):681-7. PubMed ID: 3751671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender but not stimulus parameters influence prolactin response to electroconvulsive therapy.
    Motreja S; Subbakrishna DK; Subhash MN; Gangadhar BN; Janakiramaiah N; Parameshwara G
    Psychoneuroendocrinology; 1997 Jul; 22(5):337-48. PubMed ID: 9279939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time.
    Papakostas Y; Markianos M; Pehlivanidis A; Papadimitriou GN; Zervas IM; Daras M; Stefanis C
    Biol Psychiatry; 1996 Mar; 39(6):444-7. PubMed ID: 8679790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ECT on prolactin, LH, FSH and testosterone in males with major depressive illness.
    Cooper AJ; Finlayson R; Velamoor VR; Magnus RV; Cernovsky Z
    Can J Psychiatry; 1989 Nov; 34(8):814-7. PubMed ID: 2510920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of pituitary responses to physical exercise in athletes and sedentary subjects.
    Rolandi E; Reggiani E; Franceschini R; Bavastro G; Messina V; Odaglia G; Barreca T
    Horm Res; 1985; 21(4):209-13. PubMed ID: 3924810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of stimulus intensity on prolactin and cortisol release induced by unilateral electroconvulsive therapy.
    Zis AP; Yatham LN; Lam RW; Clark CM; Srisurapanont M; McGarvey K
    Neuropsychopharmacology; 1996 Sep; 15(3):263-70. PubMed ID: 8873109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels.
    Rao ML; Stefan H; Bauer J
    Neuroendocrinology; 1989 Jan; 49(1):33-9. PubMed ID: 2716948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished TSH release after a course of ECT: altered monoamine function or seizure activity?
    Scott AI; Milner JB; Shering PA
    Psychoneuroendocrinology; 1989; 14(6):425-31. PubMed ID: 2623133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the pineal gland on pituitary function in humans.
    Rao ML; Mager T
    Psychoneuroendocrinology; 1987; 12(2):141-7. PubMed ID: 3602261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogen-stimulated neurophysin and outcome after electroconvulsive therapy.
    Scott AI; Whalley LJ; Bennie J; Bowler G
    Lancet; 1986 Jun; 1(8495):1411-4. PubMed ID: 2872518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness.
    Apéria B; Thorén M; Zettergren M; Wetterberg L
    Acta Psychiatr Scand; 1984 Oct; 70(4):361-9. PubMed ID: 6093435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The patterns of prolactin release by ECT and TRH compared.
    Markianos M; Papakostas Y; Stefanis C
    Life Sci; 1987 Sep; 41(10):1273-6. PubMed ID: 3114580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.
    Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J
    Psychopharmacology (Berl); 1982; 76(4):371-6. PubMed ID: 6812112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine studies in affective disorders. Part 1. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: effect of ECT.
    Coppen A; Rao VA; Bishop M; Abou-Saleh MT; Wood K
    J Affect Disord; 1980 Dec; 2(4):311-5. PubMed ID: 6450790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the anticholinergic drug biperiden on pituitary hormones and cortisol.
    Benkert O; Klein HE; Hofschuster E; Seibold C
    Psychoneuroendocrinology; 1981; 6(3):231-8. PubMed ID: 6794069
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolactin levels after bilateral and unilateral ECT.
    Swartz C; Abrams R
    Br J Psychiatry; 1984 Jun; 144():643-5. PubMed ID: 6743931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of plasma cortisol levels in patients with depression after treatment with bilateral electroconvulsive therapy.
    Burgese DF; Bassitt DP
    Trends Psychiatry Psychother; 2015; 37(1):27-36. PubMed ID: 25860564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.